Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Activation of peroxisome proliferator-activated receptor-α enhances fatty acid oxidation in human adipocytes.

Lee JY, Hashizaki H, Goto T, Sakamoto T, Takahashi N, Kawada T.

Biochem Biophys Res Commun. 2011 Apr 22;407(4):818-22. doi: 10.1016/j.bbrc.2011.03.106. Epub 2011 Apr 2.

PMID:
21443859
2.

Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes.

Goto T, Lee JY, Teraminami A, Kim YI, Hirai S, Uemura T, Inoue H, Takahashi N, Kawada T.

J Lipid Res. 2011 May;52(5):873-84. doi: 10.1194/jlr.M011320. Epub 2011 Feb 14.

3.

A nonthiazolidinedione peroxisome proliferator-activated receptor α/γ dual agonist CG301360 alleviates insulin resistance and lipid dysregulation in db/db mice.

Jeong HW, Lee JW, Kim WS, Choe SS, Shin HJ, Lee GY, Shin D, Lee JH, Choi EB, Lee HK, Yon GH, Cho B, Kim HR, Choi SH, Chung YS, Park SB, Chung H, Ro S, Kim JB.

Mol Pharmacol. 2010 Nov;78(5):877-85. doi: 10.1124/mol.110.065748. Epub 2010 Aug 19.

4.

The Korean traditional medicine gyeongshingangjeehwan inhibits adipocyte hypertrophy and visceral adipose tissue accumulation by activating PPARalpha actions in rat white adipose tissues.

Shin SS, Jung YS, Yoon KH, Choi S, Hong Y, Park D, Lee H, Seo BI, Lee HY, Yoon M.

J Ethnopharmacol. 2010 Jan 8;127(1):47-54. doi: 10.1016/j.jep.2009.09.052. Epub 2009 Sep 30.

PMID:
19799979
5.

Activation of peroxisome proliferator-activated receptor-α (PPARα) suppresses postprandial lipidemia through fatty acid oxidation in enterocytes.

Kimura R, Takahashi N, Murota K, Yamada Y, Niiya S, Kanzaki N, Murakami Y, Moriyama T, Goto T, Kawada T.

Biochem Biophys Res Commun. 2011 Jun 24;410(1):1-6. doi: 10.1016/j.bbrc.2011.05.057. Epub 2011 May 25.

PMID:
21640707
6.

Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist.

Chen X, Matthews J, Zhou L, Pelton P, Liang Y, Xu J, Yang M, Cryan E, Rybczynski P, Demarest K.

Metabolism. 2008 Nov;57(11):1516-25. doi: 10.1016/j.metabol.2008.06.005.

PMID:
18940388
7.
8.

Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes.

Cabrero A, Alegret M, Sánchez RM, Adzet T, Laguna JC, Vázquez M.

Diabetes. 2001 Aug;50(8):1883-90.

10.

PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.

Kim MK, Chae YN, Son MH, Kim SH, Kim JK, Moon HS, Park CS, Bae MH, Kim E, Han T, Choi HH, Shin YA, Ahn BN, Lee CH, Lim JI, Shin CY.

Eur J Pharmacol. 2008 Oct 24;595(1-3):119-25. doi: 10.1016/j.ejphar.2008.07.066. Epub 2008 Aug 12.

PMID:
18727927
11.

Changes in mRNA expression of regulatory factors involved in adipocyte differentiation during fatty acid induced adipogenesis in chicken.

Matsubara Y, Sato K, Ishii H, Akiba Y.

Comp Biochem Physiol A Mol Integr Physiol. 2005 May;141(1):108-15.

PMID:
15922639
12.

Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPARgamma activation.

Takahashi N, Goto T, Taimatsu A, Egawa K, Katoh S, Kusudo T, Sakamoto T, Ohyane C, Lee JY, Kim YI, Uemura T, Hirai S, Kawada T.

Biochem Biophys Res Commun. 2009 Dec 25;390(4):1372-6. doi: 10.1016/j.bbrc.2009.10.162. Epub 2009 Nov 3.

PMID:
19891958
13.

Peroxisome proliferator-activated receptor alpha deficiency modifies glucose handling by isolated mouse adipocytes.

Walker CG, Sugden MC, Gibbons GF, Holness MJ.

J Endocrinol. 2007 Apr;193(1):39-43.

14.
16.

Sargaquinoic acid and sargahydroquinoic acid from Sargassum yezoense stimulate adipocyte differentiation through PPARalpha/gamma activation in 3T3-L1 cells.

Kim SN, Choi HY, Lee W, Park GM, Shin WS, Kim YK.

FEBS Lett. 2008 Oct 15;582(23-24):3465-72. doi: 10.1016/j.febslet.2008.09.011. Epub 2008 Sep 17.

17.

Activation of PPARalpha and PPARgamma by environmental phthalate monoesters.

Hurst CH, Waxman DJ.

Toxicol Sci. 2003 Aug;74(2):297-308. Epub 2003 Jun 12.

18.

A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet.

Tsunoda M, Kobayashi N, Ide T, Utsumi M, Nagasawa M, Murakami K.

Am J Physiol Endocrinol Metab. 2008 May;294(5):E833-40. doi: 10.1152/ajpendo.00627.2007. Epub 2008 Jan 22.

19.

Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands.

Rival Y, Stennevin A, Puech L, Rouquette A, Cathala C, Lestienne F, Dupont-Passelaigue E, Patoiseau JF, Wurch T, Junquéro D.

J Pharmacol Exp Ther. 2004 Nov;311(2):467-75. Epub 2004 Jul 23.

20.

Lipolytic products activate peroxisome proliferator-activated receptor (PPAR) α and δ in brown adipocytes to match fatty acid oxidation with supply.

Mottillo EP, Bloch AE, Leff T, Granneman JG.

J Biol Chem. 2012 Jul 20;287(30):25038-48. doi: 10.1074/jbc.M112.374041. Epub 2012 Jun 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk